Therapy for vitiligo

Details for Australian Patent Application No. 2009228664 (hide)

Owner Clinuvel Pharmaceuticals Limited

Inventors Wolgen, Philippe

Agent Watermark

Pub. Number AU-A-2009228664

PCT Pub. Number WO2009/118191

Priority 2008901461 27.03.08 AU

Filing date 27 March 2009

Wipo publication date 1 October 2009

International Classifications

C07K 14/685 (2006.01) Peptides having more than 20 amino acids

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/37 (2006.01)

A61K 31/436 (2006.01)

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/52 (2006.01)

A61K 31/573 (2006.01)

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/34 (2006.01) Medicinal preparations containing peptides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61N 5/06 (2006.01) Radiation therapy - using light

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/118191 Priority application(s): WO2009/118191

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228701-Cooking top with improved gas top burner

2009228660-Methods for treating disorders using NMDA NR2B-subtype selective antagonist